Viewing Study NCT01275105


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2025-12-26 @ 2:10 AM
Study NCT ID: NCT01275105
Status: COMPLETED
Last Update Posted: 2012-03-06
First Post: 2011-01-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)
Sponsor: Eye Therapies, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module